Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
106.00
-3.00 (-2.75%)
At close: Dec 5, 2025

Handa Pharmaceuticals Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
909.29597.38667.05365.91263.31280.12
Upgrade
Short-Term Investments
1,7051,2321,650-19.9634.98
Upgrade
Cash & Short-Term Investments
2,6151,8292,317365.91283.27315.09
Upgrade
Cash Growth
--21.04%533.18%29.18%-10.10%-50.47%
Upgrade
Accounts Receivable
497.73190.44376.37153.487.7921.64
Upgrade
Other Receivables
7.2729.296.748.027.626.08
Upgrade
Receivables
505.01219.73383.11161.5115.427.72
Upgrade
Inventory
-41.24----
Upgrade
Prepaid Expenses
15.1712.1611.632.422.3322.38
Upgrade
Other Current Assets
2.662.663.2763.0213.3443.7
Upgrade
Total Current Assets
3,1372,1052,715592.86314.33408.9
Upgrade
Property, Plant & Equipment
88.4375.7821.0343.0441.8344.78
Upgrade
Long-Term Investments
60.1962.261.86---
Upgrade
Goodwill
35.8635.9334.9534.9534.9534.95
Upgrade
Other Intangible Assets
743.65917.050.591.071.31-
Upgrade
Long-Term Deferred Tax Assets
255.44243.52202.85117.23105.1891.08
Upgrade
Other Long-Term Assets
384.241.721.041.430.932.73
Upgrade
Total Assets
4,7053,4413,037790.56498.53582.44
Upgrade
Accounts Payable
26.3120.7813.976.221.089.36
Upgrade
Accrued Expenses
32.5235.4251.3818.5314.6117.59
Upgrade
Current Portion of Leases
10.067.275.5710.146.27.82
Upgrade
Current Income Taxes Payable
20.04-124.761.340.010.01
Upgrade
Other Current Liabilities
7.78177.8913.819.137.843.12
Upgrade
Total Current Liabilities
96.72241.36209.4945.3529.7337.9
Upgrade
Long-Term Leases
39.1132.837.6719.465.75.54
Upgrade
Long-Term Unearned Revenue
39.5839.43----
Upgrade
Long-Term Deferred Tax Liabilities
2.827.2823.814.63--
Upgrade
Other Long-Term Liabilities
37.263.1939.92---
Upgrade
Total Liabilities
215.48324.09280.8869.4435.4343.44
Upgrade
Common Stock
1,5881,4121,4111,3021,2211,157
Upgrade
Additional Paid-In Capital
2,2651,2541,253579.02338.41231.74
Upgrade
Retained Earnings
887.45546.87215.2-1,089-1,049-801
Upgrade
Treasury Stock
-114.4-56.52----
Upgrade
Comprehensive Income & Other
-135.91-39.45-123.18-70.76-47.93-48.76
Upgrade
Shareholders' Equity
4,4903,1172,756721.12463.1539
Upgrade
Total Liabilities & Equity
4,7053,4413,037790.56498.53582.44
Upgrade
Total Debt
49.1740.113.2429.5911.8913.36
Upgrade
Net Cash (Debt)
2,5651,7892,304336.32271.38301.73
Upgrade
Net Cash Growth
--22.33%584.95%23.93%-10.06%-51.01%
Upgrade
Net Cash Per Share
17.0312.6817.102.682.312.61
Upgrade
Filing Date Shares Outstanding
157.33140.48141.09130.16122.13115.7
Upgrade
Total Common Shares Outstanding
157.33140.48141.09130.16122.13115.7
Upgrade
Working Capital
3,0411,8642,505547.5284.61371
Upgrade
Book Value Per Share
28.5422.1919.545.543.794.66
Upgrade
Tangible Book Value
3,7102,1642,721685.11426.85504.05
Upgrade
Tangible Book Value Per Share
23.5815.4119.285.263.504.36
Upgrade
Machinery
-60.9555.9866.9876.0770.51
Upgrade
Leasehold Improvements
-15.312.6415.5415.4915.79
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.